↓ Skip to main content

Cochrane Database of Systematic Reviews

Olanzapine in long‐term treatment for bipolar disorder

Overview of attention for article published in Cochrane database of systematic reviews, January 2009
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (72nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user
wikipedia
12 Wikipedia pages

Citations

dimensions_citation
35 Dimensions

Readers on

mendeley
228 Mendeley
Title
Olanzapine in long‐term treatment for bipolar disorder
Published in
Cochrane database of systematic reviews, January 2009
DOI 10.1002/14651858.cd004367.pub2
Pubmed ID
Authors

Andrea Cipriani, Jennifer M Rendell, John Geddes

Abstract

Many patients with bipolar disorder require long-term treatment to prevent recurrence. Antipsychotic drugs are often used to treat acute manic episodes. It is important to clarify whether olanzapine could have a role in long-term prevention of manic and depressive relapses.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 228 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Australia 1 <1%
Brazil 1 <1%
India 1 <1%
Canada 1 <1%
Spain 1 <1%
Unknown 222 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 32 14%
Student > Bachelor 27 12%
Student > Master 26 11%
Student > Doctoral Student 15 7%
Student > Ph. D. Student 14 6%
Other 44 19%
Unknown 70 31%
Readers by discipline Count As %
Medicine and Dentistry 79 35%
Psychology 27 12%
Pharmacology, Toxicology and Pharmaceutical Science 12 5%
Nursing and Health Professions 9 4%
Neuroscience 6 3%
Other 23 10%
Unknown 72 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2021.
All research outputs
#7,336,726
of 25,382,250 outputs
Outputs from Cochrane database of systematic reviews
#8,888
of 12,981 outputs
Outputs of similar age
#45,998
of 186,005 outputs
Outputs of similar age from Cochrane database of systematic reviews
#39
of 84 outputs
Altmetric has tracked 25,382,250 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 12,981 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 186,005 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.